 Scott Wemlinger
Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 5 | 2023 | 762 | 1.000 |
Why?
| | Autoimmune Diseases | 1 | 2023 | 381 | 0.700 |
Why?
| | Lymphocyte Activation | 1 | 2022 | 1036 | 0.600 |
Why?
| | Neuromyelitis Optica | 4 | 2019 | 115 | 0.460 |
Why?
| | Aquaporin 4 | 4 | 2019 | 86 | 0.410 |
Why?
| | Neoplasms | 1 | 2023 | 2086 | 0.340 |
Why?
| | Antibodies, Monoclonal | 3 | 2023 | 1257 | 0.290 |
Why?
| | Immunoglobulin G | 4 | 2019 | 766 | 0.230 |
Why?
| | Autoantibodies | 3 | 2019 | 1347 | 0.230 |
Why?
| | Clonal Anergy | 1 | 2022 | 53 | 0.190 |
Why?
| | Receptors, Antigen, B-Cell | 2 | 2019 | 107 | 0.190 |
Why?
| | Complement C1q | 1 | 2019 | 36 | 0.160 |
Why?
| | Autoantigens | 2 | 2019 | 396 | 0.150 |
Why?
| | Autoimmunity | 1 | 2023 | 812 | 0.150 |
Why?
| | Disease Models, Animal | 3 | 2022 | 3498 | 0.130 |
Why?
| | PTEN Phosphohydrolase | 1 | 2017 | 140 | 0.130 |
Why?
| | Peptide Fragments | 1 | 2019 | 665 | 0.120 |
Why?
| | Virus Diseases | 1 | 2017 | 195 | 0.120 |
Why?
| | Mutagenesis | 1 | 2015 | 168 | 0.120 |
Why?
| | Multiple Sclerosis | 1 | 2019 | 372 | 0.110 |
Why?
| | Mice | 5 | 2022 | 14843 | 0.110 |
Why?
| | Antibody-Dependent Cell Cytotoxicity | 1 | 2013 | 19 | 0.110 |
Why?
| | Central Nervous System | 1 | 2015 | 230 | 0.110 |
Why?
| | Demyelinating Diseases | 1 | 2013 | 73 | 0.100 |
Why?
| | Lymphocytes | 1 | 2013 | 327 | 0.100 |
Why?
| | Antigens, CD | 1 | 2013 | 440 | 0.090 |
Why?
| | Nervous System Diseases | 1 | 2013 | 254 | 0.090 |
Why?
| | Animals | 6 | 2022 | 31565 | 0.080 |
Why?
| | Insulin | 1 | 2019 | 2080 | 0.080 |
Why?
| | Cricetulus | 2 | 2019 | 97 | 0.070 |
Why?
| | CHO Cells | 2 | 2019 | 137 | 0.070 |
Why?
| | Cricetinae | 2 | 2019 | 252 | 0.070 |
Why?
| | Flow Cytometry | 3 | 2015 | 1075 | 0.070 |
Why?
| | Epitopes | 2 | 2019 | 434 | 0.060 |
Why?
| | Signal Transduction | 1 | 2017 | 4501 | 0.060 |
Why?
| | Complement System Proteins | 2 | 2019 | 281 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2019 | 4680 | 0.050 |
Why?
| | Inflammation | 1 | 2013 | 2464 | 0.050 |
Why?
| | Protein Binding | 2 | 2019 | 1888 | 0.050 |
Why?
| | Humans | 7 | 2023 | 114045 | 0.050 |
Why?
| | Protein Array Analysis | 1 | 2019 | 55 | 0.040 |
Why?
| | Point Mutation | 1 | 2019 | 216 | 0.040 |
Why?
| | Astrocytes | 1 | 2019 | 159 | 0.040 |
Why?
| | Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2017 | 13 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 552 | 0.040 |
Why?
| | Hyaluronic Acid | 1 | 2019 | 189 | 0.030 |
Why?
| | Immune Tolerance | 1 | 2019 | 321 | 0.030 |
Why?
| | Receptors, CXCR4 | 1 | 2017 | 78 | 0.030 |
Why?
| | Mutation | 2 | 2019 | 3338 | 0.030 |
Why?
| | Complement Activation | 1 | 2019 | 337 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2019 | 1228 | 0.030 |
Why?
| | Antibody Formation | 1 | 2017 | 266 | 0.030 |
Why?
| | Epitope Mapping | 1 | 2015 | 51 | 0.030 |
Why?
| | Immunoglobulin Light Chains | 1 | 2015 | 36 | 0.030 |
Why?
| | Alanine | 1 | 2015 | 105 | 0.030 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2015 | 72 | 0.030 |
Why?
| | Glycine | 1 | 2015 | 152 | 0.030 |
Why?
| | Protein Structure, Secondary | 1 | 2015 | 325 | 0.030 |
Why?
| | Cell Separation | 1 | 2015 | 290 | 0.030 |
Why?
| | Peptides | 1 | 2019 | 847 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 384 | 0.030 |
Why?
| | Immunophenotyping | 1 | 2013 | 274 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 396 | 0.030 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 796 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2015 | 622 | 0.020 |
Why?
| | Proteome | 1 | 2015 | 337 | 0.020 |
Why?
| | Transfection | 1 | 2013 | 863 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 1981 | 0.020 |
Why?
| | Databases, Factual | 1 | 2015 | 1125 | 0.020 |
Why?
| | Transcriptome | 1 | 2015 | 723 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2013 | 1624 | 0.020 |
Why?
| | Female | 3 | 2019 | 59324 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2019 | 3254 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2013 | 6306 | 0.010 |
Why?
| | Male | 2 | 2017 | 55396 | 0.010 |
Why?
| | Young Adult | 1 | 2013 | 10444 | 0.010 |
Why?
| | Aged | 1 | 2013 | 18969 | 0.010 |
Why?
| | Adolescent | 1 | 2013 | 17800 | 0.010 |
Why?
| | Middle Aged | 1 | 2013 | 26605 | 0.010 |
Why?
| | Adult | 1 | 2013 | 30375 | 0.010 |
Why?
|
|
Wemlinger's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|